Data availability
The data that support the findings of this study are available on request from the corresponding author, FS.
References
Varanasi L (2023) ChatGPT creator OpenAI is in talks to sell shares in a tender offer that would double the startup’s valuation to $29 billion
Sarraju A, Bruemmer D, Van Iterson E, Cho L, Rodriguez F, Laffin L (2023) Appropriateness of cardiovascular disease prevention recommendations obtained from a popular online chat-based artificial intelligence model. JAMA 329(10):842–844
Haver HL, Ambinder EB, Bahl M, Oluyemi ET, Jeudy J, Yi PH (2023) Appropriateness of breast cancer prevention and screening recommendations provided by ChatGPT. Radiology 307:230424
Funding
None.
Author information
Authors and Affiliations
Contributions
MT and DQ- wrote the main manuscript text FS, LB, LJ- reviewed the data, reviewed patient responses All authors reviewed the manuscript
Corresponding author
Ethics declarations
Conflict of interest
None of the authors have conflict of interest pertaining to this submission. Dr. Faramarz Samie is an investigator for Castle Biosciences.
Patient consent
Not applicable.
IRB approval status
This study was reviewed and determined to be exempt.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Trager, M.H., Queen, D., Bordone, L.A. et al. Assessing ChatGPT responses to common patient queries regarding basal cell carcinoma. Arch Dermatol Res 315, 2979–2981 (2023). https://doi.org/10.1007/s00403-023-02705-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-023-02705-3